Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 23 Apr 21 424B1 Prospectus with pricing info
- 23 Apr 21 EFFECT Notice of effectiveness
-
19 Apr 21 S-1/A IPO registration (amended)
- 2 Apr 21 S-1 IPO registration
IMPL similar filings
Filing view
External links
Exhibit 23.1
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 23, 2021, except for note 14(c) as to which the date is April 19, 2021, in Amendment No.1 to the Registration Statement on Form S-1 (333-254999) and related Prospectus of Impel NeuroPharma, Inc. for the registration of its common stock.
/s/ Ernst & Young LLP
Seattle, Washington
April 19, 2021